I noticed the DIPG Phase I end data is in. This data must be coming soon the other trials are a way off though. I know data is your thing interested in your thoughts.
Study Type: Interventional (Clinical Trial) 1 ActualEnrollment: 27 participants 2 Allocation: Non-Randomized 3 Intervention Model: Parallel Assignment 4 Masking: None (Open Label) 5 Primary Purpose: Treatment 6 Official Title: Phase I Study of GDC-0084, a Brain-Penetrant PI3 Kinase/mTOR Inhibitor, in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas After Radiation Therapy 7 ActualStudy Start Date: November 19, 2018 8 ActualPrimary Completion Date: April 2, 2021 9 EstimatedStudy Completion Date: June 2023
- Forums
- ASX - By Stock
- KZA
- Latest interview
Latest interview, page-12
-
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online